A systematic review of commencing full dose antihypertensives in newly diagnosed hypertension.
Sign Up to like & getrecommendations! Published in 2025 at "Blood pressure"
DOI: 10.1080/08037051.2025.2594268
Abstract: Abstract Background Hypertension is the UK’s most common treatable cause of mortality and morbidity, including cardiovascular disease (CVD), renal disease and dementia Objective This systematic review has explored the efficacy and safety of commencing full-dose… read more here.
Keywords: review; full dose; blood; blood pressure ... See more keywords
Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2022.2130770
Abstract: ABSTRACT Introduction Two vaccine formulations are available to prevent diphtheria, tetanus, pertussis, and poliomyelitis: the pediatric full-dose (DTaP-IPV) and the reduced dose formulation (dTap-IPV). Different immunization schedules are internationally recommended for the pre-school booster dose.… read more here.
Keywords: full dose; dtap; pre school; dose dtap ... See more keywords
237: Safety of Full-Dose Anticoagulation in a Ventilated Predominantly Black Population With COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000726836.60439.80
Abstract: INTRODUCTION: Coronavirus disease 2019 (COVID-19) can be associated with coagulopathy and a high incidence of thromboembolic events These events were associated with worse clinical outcomes, especially in critically ill patients Our study investigated the safety… read more here.
Keywords: full dose; anticoagulation; ventilated predominantly; dose anticoagulation ... See more keywords
Reduction of Gadolinium-Based Contrast Agents in MRI Using Convolutional Neural Networks and Different Input Protocols
Sign Up to like & getrecommendations! Published in 2023 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000955
Abstract: Objectives The purpose of this study was to implement a state-of-the-art convolutional neural network used to synthesize artificial T1-weighted (T1w) full-dose images from corresponding noncontrast and low-dose images (using various settings of input sequences) and… read more here.
Keywords: full dose; contrast; dose; dose images ... See more keywords
Dose robustness of deep learning models for anatomic segmentation of computed tomography images
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Medical Imaging"
DOI: 10.1117/1.jmi.11.4.044005
Abstract: Abstract. Purpose The trend towards lower radiation doses and advances in computed tomography (CT) reconstruction may impair the operation of pretrained segmentation models, giving rise to the problem of estimating the dose robustness of existing… read more here.
Keywords: segmentation; full dose; segmentation models; computed tomography ... See more keywords
Abstract 4146929: Comparison of Right Ventricular Dysfunction Following Catheter-Directed, Half-Dose, and Full-Dose Thrombolysis for Acute Pulmonary Embolism
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4146929
Abstract: Introduction: Systemic thrombolysis (ST) is the mainstay of treatment for acute massive pulmonary embolism (PE). Catheter directed therapy (CDT) has become more common in treatment of acute PE in patients with contraindications to ST. Half-dose… read more here.
Keywords: pulmonary embolism; right ventricular; catheter directed; full dose ... See more keywords
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT
Sign Up to like & getrecommendations! Published in 2022 at "Circulation"
DOI: 10.1161/circulationaha.122.061533
Abstract: Background: The efficacy and safety of prophylactic full-dose anticoagulation and antiplatelet therapy in critically ill COVID-19 patients remain uncertain. Methods: COVID-PACT (Prevention of Arteriovenous Thrombotic Events in Critically-ill COVID-19 Patients Trial) was a multicenter, 2×2… read more here.
Keywords: antiplatelet; full dose; antiplatelet therapy; anticoagulation ... See more keywords
The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/2040622319887875
Abstract: Background: Observational studies suggest that patients with immunoglobulin A nephropathy (IgAN) showed good responses to corticosteroids (CS) but experienced severe adverse effects. The authors conducted a cohort study to evaluate the effectiveness and safety of… read more here.
Keywords: half rasb; full dose; effectiveness safety; half dose ... See more keywords
Safety of abbreviated dose-escalation in patients (pts) receiving glofitamab (glofit) or epcoritamab (epcor)
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-958
Abstract: Introduction Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are unique and potentially serious adverse effects associated with bispecific antibodies (BsAbs) including epco and glofit. Measures to mitigate this risk, including step-up… read more here.
Keywords: dose; response; dose escalation; pts median ... See more keywords
Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.7029
Abstract: 7029 Background: Epcor is the only SC CD3xCD20 bispecific antibody approved for R/R DLBCL. In initial protocols, hospitalization after the 1st full dose of epcor was required to monitor patients (pts) for and characterize CRS.… read more here.
Keywords: 1st full; full dose; epcor; crs ... See more keywords
Comparison analysis of different doses bevacizumab plus ICIs and interventional therapy in unresectable hepatocellular carcinoma: a real-world study
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Gastrointestinal Oncology"
DOI: 10.21037/jgo-2024-962
Abstract: Background Bevacizumab, immune checkpoint inhibitors (ICIs), interventional therapy, either alone or in combination, have demonstrated promising anti-tumor activities in unresectable hepatocellular carcinoma (HCC). However, the optimal dosing strategy for bevacizumab within combination regimens remains undetermined.… read more here.
Keywords: therapy; group; full dose; dose group ... See more keywords